Troponin testing and coronary syndrome in geriatric patients with nonspecific complaints: Are we overtesting?
Academic Emergency Medicine Dec 26, 2019
Wang AZ, et al. - Researchers investigated elderly patients (aged ≥ 65 years) with nonspecific complaints (NSCs) to determine the rate of an acute coronary syndrome (ACS) and assess the diagnostic yield of troponin testing in these patients. From January 1, 2017, to June 30, 2017, they identified 1,146 encounters; exclusion of 552 was done for fever or focal chief complaints in the provider notes. Of the remaining 594 patients, 412 (69%) underwent troponin testing, that comprised the study cohort. Findings suggest that troponin testing was undertaken frequently among elderly patients with nonspecific complaints in the emergency department; elevated troponin was observed in 20% of those tested. However, the ACS was rarely encountered in this population and the vast majority of patients with elevated troponin do not exhibit ACS. Reperfusion therapy was undertaken in any of the patients in this study. In view of the false-positive rate in this study, they do not support performing troponin testing routinely for acute coronary syndrome in this population.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries